Real-World Effectiveness of Letermovir Prophylaxis after Allogeneic Hematopoietic Cell Transplantation in a Middle-Income Country Setting

Key Points

• Letermovir prophylaxis significantly decreased the incidence of cytomegalovirus infections.
• In a cohort of 150 patients, the overall infection rate dropped to 20% with treatment.
• Analysis of data from multiple centers in a middle-income country highlights the intervention's effectiveness.
• Results indicate a potential benefit for immunosuppressed patients after transplantation.